T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Albany International
AIN
$1.82B
| $30.9M | 0.01% |
313,231
-35,795
| -10% | -$3.42M |
|
802
Wabtec
WAB
$50.3B
| $30.7M | ﹤0.01% |
307,796
+1,133
| +0.4% | +$108K |
|
|
ARCE
803
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $30.5M | ﹤0.01% |
2,257,627
+38,218
| +2% | +$428K |
|
|
ENV
804
DELISTED
ENVESTNET, INC.
ENV
| $30.4M | ﹤0.01% |
493,439
-72,549
| -13% | -$3.86M |
|
|
MORF
805
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $30.2M | ﹤0.01% |
1,129,997
-9,772
| -0.9% | -$267K |
|
806
IDEAYA Biosciences
IDYA
$3.53B
| $30.2M | ﹤0.01% |
1,663,528
-195,349
| -11% | -$3.29M |
|
|
PRFT
807
DELISTED
Perficient Inc
PRFT
| $30.1M | ﹤0.01% |
431,675
+1,496
| +0.3% | +$103K |
|
808
Church & Dwight Co
CHD
$24B
| $30M | ﹤0.01% |
372,590
+1,182
| +0.3% | +$90.7K |
|
809
Keros Therapeutics
KROS
$211M
| $29.8M | ﹤0.01% |
621,189
+611,459
| +6,284% | +$28.6M |
|
|
AEPPZ
810
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| – | – |
0
| – | – |
|
811
eBay
EBAY
$46.5B
| $29.3M | ﹤0.01% |
706,997
-14,286
| -2% | -$592K |
|
812
Grand Canyon Education
LOPE
$3.79B
| $29.3M | ﹤0.01% |
277,368
+261,125
| +1,608% | +$26M |
|
813
Flowserve
FLS
$10.3B
| $29.3M | ﹤0.01% |
953,368
-22,332
| -2% | -$652K |
|
|
FTCH
814
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $29.2M | ﹤0.01% |
6,170,514
+1,251,443
| +25% | +$8.72M |
|
815
Cognex
CGNX
$10.4B
| $29.1M | ﹤0.01% |
618,132
-122,991
| -17% | -$5.76M |
|
816
Skyworks Solutions
SWKS
$10.5B
| $29M | ﹤0.01% |
318,634
-327
| -0.1% | -$29.3K |
|
817
East-West Bancorp
EWBC
$18.6B
| $29M | ﹤0.01% |
439,393
-30,699
| -7% | -$2.1M |
|
818
Hilton Grand Vacations
HGV
$3.49B
| $29M | ﹤0.01% |
751,316
+2,561
| +0.3% | +$101K |
|
819
Uber
UBER
$155B
| $28.8M | ﹤0.01% |
1,163,591
+33,483
| +3% | +$916K |
|
820
Synaptics
SYNA
$4.2B
| $28.6M | ﹤0.01% |
300,500
-21,692
| -7% | -$2.08M |
|
|
GBIO
821
DELISTED
Generation Bio
GBIO
| $28.5M | ﹤0.01% |
726,105
-13,452
| -2% | -$706K |
|
822
Tenable Holdings
TENB
$4.41B
| $28.4M | ﹤0.01% |
744,816
-42,879
| -5% | -$1.57M |
|
|
ITCI
823
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $28.2M | ﹤0.01% |
532,137
+181,181
| +52% | +$9.08M |
|
824
Leidos
LDOS
$17.9B
| $28M | ﹤0.01% |
266,564
+1,657
| +0.6% | +$170K |
|
825
Monte Rosa Therapeutics
GLUE
$1.35B
| $28M | ﹤0.01% |
3,683,430
-79,956
| -2% | -$666K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.